These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2606820)

  • 21. [Bactericidal activity of combinations of ticarcillin-clavulanic acid or other beta-lactams (amoxicillin, piperacillin-tazobactam, ticarcillin) with gentamicin against Enterococcus faecalis and E. faecium].
    Leclercq R; Duval J
    Pathol Biol (Paris); 1995 Apr; 43(4):245-52. PubMed ID: 7567109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic susceptibility of anaerobic bacteria isolated in Johannesburg.
    van der Westhuyzen I; Chalkley LJ
    S Afr Med J; 1992 Nov; 82(5):314-7. PubMed ID: 1448710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association experiments with aerobic and anaerobic pathogens: a model of in-vitro susceptibility testing in mixed infections. Activity of enoxacin, clindamycin, and metronidazole.
    Heizmann WR; Schmid R; Heilmann F; Werner H
    Infection; 1989; 17(3):160-4. PubMed ID: 2737759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of low concentrations of clavulanic acid on the in-vitro activity of amoxycillin against beta-lactamase-producing Branhamella catarrhalis and Haemophilus influenzae.
    Cooper CE; Slocombe B; White AR
    J Antimicrob Chemother; 1990 Sep; 26(3):371-80. PubMed ID: 2121699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Augmentation effect of clavulanic acid with penicillin, cephalothin and ticarcillin against Bacteroides fragilis.
    Bansal MB; Chuah SK; Oryema-Lalobo M; Thadepalli H
    Chemotherapy; 1985; 31(3):173-7. PubMed ID: 3996086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clavulanate-potentiated amoxycillin: activity in vitro and bioavailability in the dog.
    Bywater RJ; Palmer GH; Buswell JF; Stanton A
    Vet Rec; 1985 Jan; 116(2):33-6. PubMed ID: 3871985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The study of drug resistance in aerobic and anaerobic bacterial flora to selected antibacterial drugs].
    Michalska W; Chylak J; Pietkiewicz K
    Med Dosw Mikrobiol; 1996; 48(1-2):61-70. PubMed ID: 8926770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [In vitro activity of a combination of amoxicillin-clavulanic acid on anaerobic bacteria].
    Sedallian A; Roudon T
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):678-81. PubMed ID: 3054746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of ticarcillin/clavulanate on the intestinal microflora.
    Nord CE; Bergan T; Thorsteinsson SB
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():221-6. PubMed ID: 2606816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The activity of ticarcillin in combination with clavulanic acid against Bacteroides species: an in-vitro comparison with other antibiotics.
    de Barbeyrac B; Quentin C; Bébéar C
    J Antimicrob Chemother; 1986 May; 17 Suppl C():35-9. PubMed ID: 3636337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity of clavulanate-potentiated penicillins against methicillin-resistant Staphylococcus aureus.
    Graninger W; Leitha T; Griffin K; Witte W; Svacina W
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():49-54. PubMed ID: 2606819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Etiology and treatment of post-cesarean-section endometritis after cephalosporin prophylaxis.
    Hillier S; Watts DH; Lee MF; Eschenbach DA
    J Reprod Med; 1990 Mar; 35(3 Suppl):322-8. PubMed ID: 2181119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of amoxycillin/clavulanic acid on the aerobic and anaerobic tonsillar microflora in the treatment of recurrent tonsillitis.
    Agren K; Lundberg C; Nord CE
    Scand J Infect Dis; 1990; 22(6):691-7. PubMed ID: 2284575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents.
    Citron DM; Goldstein EJ; Merriam CV; Lipsky BA; Abramson MA
    J Clin Microbiol; 2007 Sep; 45(9):2819-28. PubMed ID: 17609322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum bactericidal activity against aerobes and anaerobes of volunteers receiving cefoxitin or cefotetan.
    Cruciani M; Navarra A; Bono L; Concia E
    Chemioterapia; 1988 Aug; 7(4):261-3. PubMed ID: 3180306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibacterial activities of amoxicillin alone and in combination with clavulanic acid correlated with beta-lactamase production.
    Hsu LY; Chang SC; Luh KT; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):272-80. PubMed ID: 1818798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prevalence of beta-lactamase producing bacteria in subgingival plaque and their sensitivity to Augmentin.
    Legg JA; Wilson M
    Br J Oral Maxillofac Surg; 1990 Jun; 28(3):180-4. PubMed ID: 1983762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibility of Escherichia coli isolates with TEM-1 beta-lactamase to combinations of BRL42715, tazobactam or clavulanate with piperacillin or amoxycillin .
    Livermore DM; Seetulsingh P
    J Antimicrob Chemother; 1991 Jun; 27(6):761-7. PubMed ID: 1669013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions of tazobactam and clavulanate with inducibly- and constitutively-expressed Class I beta-lactamases.
    Akova M; Yang Y; Livermore DM
    J Antimicrob Chemother; 1990 Feb; 25(2):199-208. PubMed ID: 2158496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of sulbactam in an in vitro model of mixed aerobic/anaerobic infections.
    Heizmann WR; Heilmann F; Egeler B; Werner H
    Infection; 1990; 18(2):117-21. PubMed ID: 2332245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.